CUMBERLAND PHARMACEUTICALS
Live / Allowed — Published for opposition (as of 24 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99184913
- Mark type
- Stylized text
- Filed
- 14 May 2025
- Published for opposition
- 24 Feb 2026
- Attorney of record
- Haverly MacArthur
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of pain, fever, nausea, bacterial infections, gastrointestinal illness, cardiology diseases, and rare diseases in acute care, oncology, infectious diseases, gastroenterology and rare disease patients
Owner
- Cumberland Pharmaceuticals Inc., Nashville, TN, US
- Cumberland Pharmaceuticals Inc., Nashville, TN, US
Prior registrations
Prosecution history
- 24 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Feb 2026 — PUBLISHED FOR OPPOSITION
- 18 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Sept 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Sept 2025 — NON-FINAL ACTION E-MAILED
- 29 Sept 2025 — NON-FINAL ACTION WRITTEN
- 27 Sept 2025 — ASSIGNED TO EXAMINER
- 14 May 2025 — APPLICATION FILING RECEIPT MAILED
- 14 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 May 2025 — NEW APPLICATION ENTERED